Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus

Details for Australian Patent Application No. 2006260477 (hide)

Owner deCODE Genetics ehf.

Inventors Grant, Struan F. A.

Agent Freehills

Pub. Number AU-B-2006260477

PCT Pub. Number WO2006/137085

Priority 60/757,155 06.01.06 US; 60/692,174 20.06.05 US

Filing date 16 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 23 February 2012

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/137085 Priority application(s): WO2006/137085

7 February 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name deCODE Genetics ehf., Application No. 2006260477, under INID (54), correct the title to read Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus.

23 February 2012 Application Accepted

  Published as AU-B-2006260477

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006260482-Process and apparatus for treating exhausted abrasive slurries for the recovery of their reusable components

2006260476-Process for the manufacture of biorelease fertilizers of zinciron-manganese, iron-manganese copper and zinc-iron-manganese-copper